San Francisco, CA, United States of America

Charles Noble

This inventor holds 23 USPTO granted patents and 23 published patent applications, plus 2 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Akagera Medicines, Inc., Zoneone Pharma, Inc., Ipsen Biopharm Limited. Active years: 1976-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Noble. Retrieved from https://idiyas.com/inventor/charles-noble

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 23)

% Patents Active = 91.3

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 2.0

ph-index = 7

Forward Citations = 104(Granted Patents)

Location History:

Birmingham, AL (US) (1976 - 2005)
San Francisco, CA (US) (2017 - 2024)

Company Filing History:

6 out of 10

Akagera Medicines, Inc.

Ipsen Biopharm Limited

patents

4. 2 out of 25

Celator Pharmaceuticals, Inc.

patents

5. 8 out of 834,601

Other

patents

Years Active: 1976-2026

Loading Chart...

Areas of Expertise:

Oxazolidinone Compounds

Liposome Compositions

Water-Soluble Drugs

Pharmaceutical Stabilization

Centrifugal Casting

Ductile Cast Iron

Metal Casting

Cold Extrusion

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12753170 - Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof (2026-10-06),

2. 12747236 - Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof (2026-09-29),

3. 12145928 - Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof (2024-11-19),

4. 12116361 - Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof (2024-10-15),

5. 12070471 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2024-08-27),

6. 12059497 - Stabilizing camptothecin pharmaceutical compositions (2024-08-13),

7. 11583544 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2023-02-21),

8. 11566023 - Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof (2023-01-31),

9. 11555033 - Oxazolidinone compounds, liposome compositions comprising oxazolidinone compounds and method of use thereof (2023-01-17),

10. 10993914 - Stabilizing camptothecin pharmaceutical compositions (2021-05-04),

11. 10722467 - Remote loading of sparingly water-soluble drugs into liposomes (2020-07-28),

12. 10507182 - Remote loading of sparingly water-soluble drugs into liposomes (2019-12-17),

13. 10456360 - Stabilizing camptothecin pharmaceutical compositions (2019-10-29),

14. 10004759 - Remote loading of sparingly water-soluble drugs into lipid vesicles (2018-06-26),

15. 9737485 - Remote loading of sparingly water-soluble drugs into liposomes (2017-08-22),

Title: Charles Noble: Pioneering Inventor from San Francisco

Introduction: Charles Noble is a renowned inventor based in San Francisco, CA, known for his groundbreaking contributions to various industries.

Latest Patents: Charles Noble holds several patents in the fields of technology, healthcare, and sustainable energy, with his most recent inventions focusing on renewable energy solutions.

Career Highlights: With a career spanning over two decades, Charles Noble has established himself as a leading figure in the innovation landscape, with his inventions revolutionizing the way we approach everyday challenges.

Collaborations: Throughout his career, Charles Noble has collaborated with top research institutions, universities, and companies to bring his inventions to life, showcasing his ability to work across disciplines for impactful results.

Conclusion: Charles Noble's dedication to innovation and his passion for creating a better future through his inventions make him a true pioneer in the world of technology and beyond.

Profile summary based on public USPTO records.